ES2188580T3 - Sistema para uso en un metodo de tratamiento terapeutico o de diagnostico. - Google Patents
Sistema para uso en un metodo de tratamiento terapeutico o de diagnostico.Info
- Publication number
- ES2188580T3 ES2188580T3 ES90914303T ES90914303T ES2188580T3 ES 2188580 T3 ES2188580 T3 ES 2188580T3 ES 90914303 T ES90914303 T ES 90914303T ES 90914303 T ES90914303 T ES 90914303T ES 2188580 T3 ES2188580 T3 ES 2188580T3
- Authority
- ES
- Spain
- Prior art keywords
- medical agent
- therapeutic
- diagnostic treatment
- treatment method
- normal clearance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
- A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
Abstract
ES UN METODO DE TRATAMIENTO TERAPEUTICO O DIAGNOSTICO USANDO UN AGENTE MEDICO, EN EL CUAL HABRA EFECTOS BENEFICIOSOS SI EL NIVEL DE CIRCULACION DE DICHO AGENTE SE REDUCE ARTIFICIALMENTE MAS RAPIDAMENTE, QUE MEDIANTE LA REDUCCION POR EL ACLARAMIENTO NORMAL O POR VIAS QUE EVITEN LOS MECANISMOS NORMALES DE ACLARAMIENTO. EL METODO INCLUYE LA EXTRACCION EXTRACORPOREA DEL AGENTE MEDICO PASANDO EL LIQUIDO CORPORAL DEL PACIENTE POR UN SOPORTE ADAPTADO PARA EXTRAER SELECTIVAMENTE EL AGENTE MEDICO.-
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38866489A | 1989-08-02 | 1989-08-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2188580T3 true ES2188580T3 (es) | 2003-07-01 |
Family
ID=23535010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90914303T Expired - Lifetime ES2188580T3 (es) | 1989-08-02 | 1990-08-02 | Sistema para uso en un metodo de tratamiento terapeutico o de diagnostico. |
Country Status (6)
Country | Link |
---|---|
US (2) | US5474772A (es) |
EP (1) | EP1327454A3 (es) |
AT (1) | ATE233100T1 (es) |
DE (1) | DE69034042T2 (es) |
DK (1) | DK0436717T3 (es) |
ES (1) | ES2188580T3 (es) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9100142L (sv) * | 1991-01-17 | 1992-07-18 | Bengt Sandberg | En metod och ett system foer foerbaettrad in vivo reducering av diagnostiska och/eller terapeutiska substanser medelst extrakorporeal borttagning, och anvaendandet av naemnda substanser foer detta aendamaal |
US5753227A (en) * | 1993-07-23 | 1998-05-19 | Strahilevitz; Meir | Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases |
US7166295B1 (en) | 1995-05-26 | 2007-01-23 | Meir Strahilevitz | Methods of treatment and diagnostic visualization, particularly in cancer |
US20010023288A1 (en) * | 1999-07-07 | 2001-09-20 | Wilbur D. Scott | Trifunctional reagent for conjugation to a biomolecule |
WO2000002050A1 (en) * | 1998-07-07 | 2000-01-13 | Department Of Radiation Oncology, University Of Washington | Trifunctional reagent for conjugation to a biomolecule |
US7011812B1 (en) | 1996-05-03 | 2006-03-14 | Immunomedics, Inc. | Targeted combination immunotherapy of cancer and infectious diseases |
JP2000510119A (ja) * | 1996-05-03 | 2000-08-08 | イムノメディクス,インコーポレイテッド | ガンに対する標的コンビネーション免疫療法 |
US5817770A (en) | 1997-03-21 | 1998-10-06 | Drug Abuse Sciences, Inc. | Cocaethylene immunogens and antibodies |
EP1351712B1 (en) * | 2000-06-20 | 2007-08-01 | Immunomedics, Inc. | Targeted combination immunotherapy of cancer and infectious diseases |
AU2001296124A1 (en) * | 2000-10-12 | 2002-04-22 | Mitra Medical Technology Ab | Kit for intraperitoneal administration and extracorpeal removal of a drug |
WO2004024099A2 (en) * | 2002-04-02 | 2004-03-25 | Scantibodies Laboratory, Inc. | Methods and devices for treating severe peripheral bacterial infections |
EP1507557A4 (en) * | 2002-04-23 | 2006-06-14 | Meir Strahilevitz | METHODS AND DEVICES FOR TARGETING A SITE IN A MAMMAL AND DETERMINING CHEMICAL SPECIES FROM A MAMMAL |
JP2008508952A (ja) * | 2004-08-04 | 2008-03-27 | アスピラ バイオシステムズ, インコーポレイテッド | 部分的分子インプリントを用いる体液からの生体分子の捕獲および除去 |
CN102512186B (zh) | 2004-11-16 | 2015-07-15 | 拜耳医疗保健公司 | 确定病人传输函数以及建模病人对药物注射的响应 |
DK2990073T3 (en) | 2004-11-24 | 2018-08-13 | Bayer Healthcare Llc | DEVICES AND SYSTEMS FOR DELIVERING FLUIDS |
JP2006248978A (ja) * | 2005-03-10 | 2006-09-21 | Mebiopharm Co Ltd | 新規なリポソーム製剤 |
WO2008085421A2 (en) | 2006-12-29 | 2008-07-17 | Medrad, Inc. | Patient-based parameter generation systems for medical injection procedures |
JP5437240B2 (ja) | 2007-07-17 | 2014-03-12 | メドラッド インコーポレーテッド | 心肺機能の評価、及び流体搬送の手順のパラメータを決定する装置、システム及び方法 |
US8165663B2 (en) * | 2007-10-03 | 2012-04-24 | The Invention Science Fund I, Llc | Vasculature and lymphatic system imaging and ablation |
US8285367B2 (en) * | 2007-10-05 | 2012-10-09 | The Invention Science Fund I, Llc | Vasculature and lymphatic system imaging and ablation associated with a reservoir |
US8285366B2 (en) | 2007-10-04 | 2012-10-09 | The Invention Science Fund I, Llc | Vasculature and lymphatic system imaging and ablation associated with a local bypass |
US9421330B2 (en) | 2008-11-03 | 2016-08-23 | Bayer Healthcare Llc | Mitigation of contrast-induced nephropathy |
US8721618B2 (en) | 2009-02-25 | 2014-05-13 | The Invention Science Fund I, Llc | Device for actively removing a target cell from blood or lymph of a vertebrate subject |
US8317737B2 (en) | 2009-02-25 | 2012-11-27 | The Invention Science Fund I, Llc | Device for actively removing a target component from blood or lymph of a vertebrate subject |
US8430831B2 (en) * | 2009-02-25 | 2013-04-30 | The Invention Science Fund I, Llc | Device, system, and method for controllably reducing inflammatory mediators in a subject |
US8246565B2 (en) * | 2009-02-25 | 2012-08-21 | The Invention Science Fund I, Llc | Device for passively removing a target component from blood or lymph of a vertebrate subject |
US20110295175A1 (en) * | 2010-03-16 | 2011-12-01 | Marv Enterprises Llc | Sequential Extracoporeal Treatment of Bodily Fluids |
BR112012033116A2 (pt) | 2010-06-24 | 2016-10-25 | Medrad Inc | modelagem da propagação de fármaco e geração de parâmetro para protocolos de injeção |
JP6193978B2 (ja) | 2012-05-14 | 2017-09-06 | バイエル・ヘルスケア・エルエルシーBayer HealthCare LLC | X線管電圧に基づいた薬剤流体注入プロトコルの判定システム及び方法 |
US9555379B2 (en) | 2013-03-13 | 2017-01-31 | Bayer Healthcare Llc | Fluid path set with turbulent mixing chamber, backflow compensator |
WO2017152036A1 (en) | 2016-03-03 | 2017-09-08 | Bayer Healthcare Llc | System and method for improved fluid delivery in multi-fluid injector systems |
US11339209B2 (en) | 2016-11-14 | 2022-05-24 | Novartis Ag | Compositions, methods, and therapeutic uses related to fusogenic protein minion |
JP7346309B2 (ja) | 2017-08-31 | 2023-09-19 | バイエル・ヘルスケア・エルエルシー | 流体送達性能を改善するための流体経路インピーダンス評価 |
JP7221885B2 (ja) | 2017-08-31 | 2023-02-14 | バイエル・ヘルスケア・エルエルシー | 注入器圧力較正システムおよび方法 |
JP2020532336A (ja) | 2017-08-31 | 2020-11-12 | バイエル・ヘルスケア・エルエルシーBayer HealthCare LLC | 流体インジェクタシステムにおける動的圧力制御のための方法 |
AU2018326386B2 (en) | 2017-08-31 | 2024-03-28 | Bayer Healthcare Llc | Fluid injector system volume compensation system and method |
US11786652B2 (en) | 2017-08-31 | 2023-10-17 | Bayer Healthcare Llc | System and method for drive member position and fluid injector system mechanical calibration |
GB201717555D0 (en) * | 2017-10-25 | 2017-12-06 | Nonwovens Innovation & Res Institute Ltd | Blood filter |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4375414A (en) * | 1971-05-20 | 1983-03-01 | Meir Strahilevitz | Immunological methods for removing species from the blood circulatory system and devices therefor |
US4371515A (en) * | 1978-12-26 | 1983-02-01 | E-Y Laboratories, Inc. | Method for forming an isolated lectin-immunological conjugate |
US4223672A (en) * | 1979-02-08 | 1980-09-23 | Baxter Travenol Laboratories, Inc. | Variable volume plasma treatment chamber for an apparatus for the extracorporeal treatment of disease |
US4215688A (en) * | 1979-02-09 | 1980-08-05 | Baxter Travenol Laboratories, Inc. | Apparatus for the extracorporeal treatment of disease |
US4350156A (en) * | 1980-05-29 | 1982-09-21 | Japan Foundation For Artificial Organs | Method and apparatus for on-line filtration removal of macromolecules from a physiological fluid |
US4824432A (en) * | 1981-03-24 | 1989-04-25 | S.V.S. Laboratories, Inc. | Method for treating AIDS and other immune deficiencies and immune disorders |
US4687808A (en) * | 1982-08-12 | 1987-08-18 | Biospecific Technologies, Inc. | Activation of biocompatible polymers with biologicals whose binding complements are pathological effectors |
CA1221307A (en) * | 1982-12-02 | 1987-05-05 | Nobutaka Tani | Adsorbent and process for preparing the same |
CA1236738A (en) * | 1983-06-01 | 1988-05-17 | Mark R. Honard | Therapeutic device |
US4551435A (en) * | 1983-08-24 | 1985-11-05 | Immunicon, Inc. | Selective removal of immunospecifically recognizable substances from solution |
DK525384D0 (da) * | 1984-11-05 | 1984-11-05 | Nordisk Insulinlab | Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat |
US4863713A (en) * | 1986-06-23 | 1989-09-05 | The Board Of Trustees Of Leland Stanford Jr. Univ. | Method and system for administering therapeutic and diagnostic agents |
US4877599A (en) * | 1986-11-10 | 1989-10-31 | New England Deaconess Hospital Corporation | Detection of vascular disease with labelled antibodies |
US5122112A (en) * | 1986-11-21 | 1992-06-16 | Imre Corporation | Antigen-specific removal of circulating immune complexes |
US4800016A (en) * | 1986-11-24 | 1989-01-24 | The University Of Michigan | Extracorporeal blood de-heparinization system |
DE3705637A1 (de) * | 1987-02-21 | 1988-09-29 | Bissendorf Peptide Gmbh | Vorrichtung zur entfernung von lokal applizierten wirkstoffen gegen solide tumoren |
US4846786A (en) * | 1987-04-30 | 1989-07-11 | Massachusetts Institute Of Technology | Bioreactor containing suspended, immobilized species |
US4885207A (en) * | 1987-07-13 | 1989-12-05 | Uop | Biocompatible protein or ligand immobilization system |
US4865841A (en) * | 1987-10-23 | 1989-09-12 | Imre Corporation | Methods and compositions for transient elimination of humoral immune antibodies |
US5069662A (en) * | 1988-10-21 | 1991-12-03 | Delcath Systems, Inc. | Cancer treatment |
US5149425A (en) * | 1988-11-09 | 1992-09-22 | Chembiomed, Ltd. | Affinity supports for hemoperfusion |
KR0185967B1 (ko) * | 1989-01-23 | 1999-05-01 | 에프. 쥐. 엠. 헤르만스; 에이. 쥐. 제이. 베르미렌 | 치료용 약물의 부위 특이적 생체내 활성작용 |
US5252466A (en) * | 1989-05-19 | 1993-10-12 | Biotechnology Research And Development Corporation | Fusion proteins having a site for in vivo post-translation modification and methods of making and purifying them |
EP0436717B1 (en) * | 1989-08-02 | 2003-02-26 | Mitra Medical Technology AB | System for use in a method of therapeutic or diagnostic treatment |
SE9100142L (sv) * | 1991-01-17 | 1992-07-18 | Bengt Sandberg | En metod och ett system foer foerbaettrad in vivo reducering av diagnostiska och/eller terapeutiska substanser medelst extrakorporeal borttagning, och anvaendandet av naemnda substanser foer detta aendamaal |
-
1990
- 1990-08-02 US US07/562,009 patent/US5474772A/en not_active Expired - Lifetime
- 1990-08-02 ES ES90914303T patent/ES2188580T3/es not_active Expired - Lifetime
- 1990-08-02 DE DE69034042T patent/DE69034042T2/de not_active Expired - Fee Related
- 1990-08-02 AT AT90914303T patent/ATE233100T1/de not_active IP Right Cessation
- 1990-08-02 DK DK90914303T patent/DK0436717T3/da active
- 1990-08-02 EP EP03075542A patent/EP1327454A3/en not_active Withdrawn
-
1995
- 1995-05-04 US US08/434,889 patent/US6046225A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1327454A3 (en) | 2003-12-03 |
US5474772A (en) | 1995-12-12 |
ATE233100T1 (de) | 2003-03-15 |
DE69034042D1 (de) | 2003-04-03 |
US6046225A (en) | 2000-04-04 |
DE69034042T2 (de) | 2003-07-17 |
DK0436717T3 (da) | 2003-05-05 |
EP1327454A2 (en) | 2003-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2188580T3 (es) | Sistema para uso en un metodo de tratamiento terapeutico o de diagnostico. | |
SE9100142D0 (sv) | A method and a system for enhanced in vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion, and the use of said agents for said purpose | |
ES525919A0 (es) | Sistema de hemodialisis para el tratamiento de pacientes | |
IT8221820A0 (it) | Metodo e sistema per il trattamento extracorporeo del sangue. | |
BR9914969A (pt) | Métodos para formar imagem, tratar e localizar tecido doente, e, dispositivo integrado de formação de imagem e de tratamento | |
ES556380A0 (es) | Un dispositivo medico para la administracion transdermica de un agente biologico | |
DE3770305D1 (de) | Pumpenkoerper zum anschluss einer bestrahlungskammer an ein system zur behandlung eines patienten durch photoaktivierung. | |
PT93791A (pt) | Dispositivo para tratamento de residuos medicos especiais | |
DE68907402D1 (de) | Durchflussregler fuer medizinloesungen oder fuer bluttransfusionsgeraete. | |
DE58908452D1 (de) | Medizinisches Gerät zur Diagnose und/oder Therapie. | |
DE69116380D1 (de) | Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit | |
DE3767196D1 (de) | Ventileinrichtung fuer ein system zur behandlung eines patienten durch photoaktivierung. | |
NO175023C (no) | Fremgangmåte for in vitro diagnostisering av en innflammasjonssykdom indusert av immunkomplekser som er i omlöp, og fremgangsmåte for fremstilling av dsRNA til den in vitro diagnostisering | |
Stone et al. | Mobilization of Radioactive Sodium from the Gastrocnemius Muscle of the Dog. | |
BR8905985A (pt) | Composicao liquida aquosa para tratamento de tecidos | |
CA2037933A1 (en) | Method of Treatment with Medical Agents | |
MX155537A (es) | Sistema terapeutico para tratamiento extracorporal | |
GB2108400A (en) | Method and apparatus for treating blood and the like | |
IT7822027A0 (it) | Apparecchio medicale per la cura della trombosi venale profonda. | |
ES2101311T3 (es) | Utilizacion de un dispositivo transdermico que contiene (e)-2-(p-fluorofenetil)-3-fluoroalilamina y su uso para el tratamiento de la enfermedad de alzheimer. | |
IT8148480A0 (it) | Composizione terapeutica e sistema per il trattamento extracorporeo di sangue intero | |
SU826588A1 (ru) | Способ консервативного лечени неврологических синдромов при шейном остеохондрозе | |
ES556906A0 (es) | Sistema de control de la temperatura de la sangre de un paciente en cirujia cardiaca | |
SE8603746D0 (sv) | System for extracorporeal blodbehandling | |
NO960866L (no) | Fremgangsmåte til behandling av leversykdom og lignende indikasjoner med vasodilaterende midler |